Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc. (TARS), sold 1,154 shares at $16.90 ($20K) on 2022-12-02, disclosed to the SEC on 2022-12-06.
Open-market sale of $20k TARS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TARS | SELL | 2024-03-19 | $271K | — | Filing → |
| TARS | SELL | 2023-12-01 | $273K | — | Filing → |
| TARS | SELL | 2023-03-23 | $14K | — | Filing → |